TDP-43 N-terminal domain dimerisation or spatial separation by RNA binding decreases its propensity to aggregate

FEBS Lett. 2023 Jun;597(12):1667-1676. doi: 10.1002/1873-3468.14635. Epub 2023 May 26.

Abstract

Aggregation of the 43 kDa TAR DNA-binding protein (TDP-43) is a pathological hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). RNA binding and TDP-43 N-terminal domain dimerisation has been suggested to ameliorate TDP-43 aggregation. However, the relationship between these factors and the solubility of TDP-43 is largely unknown. Therefore, we developed new oligonucleotides that can recruit two TDP-43 molecules and interfere with their intermolecular interactions via spatial separation. Using these oligonucleotides and TDP-43-preferable UG-repeats, we uncovered two distinct mechanisms for modulating TDP-43 solubility by RNA binding: One is N-terminal domain dimerisation, and the other is the spatial separation of two TDP-43 molecules. This study provides new molecular insights into the regulation of TDP-43 solubility.

Keywords: ALS; FTLD; N-terminal domain interaction; RNA binding; TDP-43; UG-repeats; aggregation; dimerisation; solubility; spatial organisation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyotrophic Lateral Sclerosis* / metabolism
  • DNA-Binding Proteins / metabolism
  • Frontotemporal Lobar Degeneration* / metabolism
  • Humans
  • Inclusion Bodies / metabolism
  • RNA / genetics
  • RNA / metabolism

Substances

  • DNA-Binding Proteins
  • RNA